Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Csilla Ozvegy-Laczka

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
FEBS Letters|May 29, 2004
ABCG2 -- a transporter for all seasonsBalázs Sarkadi, Csilla Ozvegy-Laczka, Katalin Német, et al.
Drug Discovery Today|May 13, 2008
The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox)Gergely Szakács, András Váradi, Csilla Ozvegy-Laczka, et al.
Current Cancer Drug Targets|May 16, 2009
Interaction of ABC multidrug transporters with anticancer protein kinase inhibitors: substrates and/or inhibitors?Csilla Hegedus, Csilla Ozvegy-Laczka, Gergely Szakács, et al.
Biochimica Et Biophysica Acta|January 27, 2005
Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognitionCsilla Ozvegy-Laczka, Gabriella Köblös, Balázs Sarkadi, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 9, 2005
Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transportersCsilla Ozvegy-Laczka, Judit Cserepes, N Barry Elkind, et al.
Frontiers in Pharmacology|December 7, 2013
ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivityCharlotte Gauthier, Csilla Ozvegy-Laczka, Gergely Szakacs, et al.
Cancer Letters|December 13, 2005
The role of the human ABCG2 multidrug transporter and its variants in cancer therapy and toxicologyJudit Cervenak, Hajnalka Andrikovics, Csilla Ozvegy-Laczka, et al.
Biochemical and Biophysical Research Communications|January 10, 2008
Combined localization and real-time functional studies using a GFP-tagged ABCG2 multidrug transporterTamás I Orbán, László Seres, Csilla Ozvegy-Laczka, et al.
Biochimica Et Biophysica Acta|July 31, 2007
Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporterAgnes Telbisz, Marianna Müller, Csilla Ozvegy-Laczka, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2005
Single nucleotide polymorphisms modify the transporter activity of ABCG2Kuniaki Morisaki, Robert W Robey, Csilla Ozvegy-Laczka, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
FEBS Letters|May 29, 2004
ABCG2 -- a transporter for all seasonsBalázs Sarkadi, Csilla Ozvegy-Laczka, Katalin Német, et al.
Drug Discovery Today|May 13, 2008
The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox)Gergely Szakács, András Váradi, Csilla Ozvegy-Laczka, et al.
Current Cancer Drug Targets|May 16, 2009
Interaction of ABC multidrug transporters with anticancer protein kinase inhibitors: substrates and/or inhibitors?Csilla Hegedus, Csilla Ozvegy-Laczka, Gergely Szakács, et al.
Biochimica Et Biophysica Acta|January 27, 2005
Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognitionCsilla Ozvegy-Laczka, Gabriella Köblös, Balázs Sarkadi, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 9, 2005
Tyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transportersCsilla Ozvegy-Laczka, Judit Cserepes, N Barry Elkind, et al.
Frontiers in Pharmacology|December 7, 2013
ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivityCharlotte Gauthier, Csilla Ozvegy-Laczka, Gergely Szakacs, et al.
Cancer Letters|December 13, 2005
The role of the human ABCG2 multidrug transporter and its variants in cancer therapy and toxicologyJudit Cervenak, Hajnalka Andrikovics, Csilla Ozvegy-Laczka, et al.
Biochemical and Biophysical Research Communications|January 10, 2008
Combined localization and real-time functional studies using a GFP-tagged ABCG2 multidrug transporterTamás I Orbán, László Seres, Csilla Ozvegy-Laczka, et al.
Biochimica Et Biophysica Acta|July 31, 2007
Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporterAgnes Telbisz, Marianna Müller, Csilla Ozvegy-Laczka, et al.
Cancer Chemotherapy and Pharmacology|April 20, 2005
Single nucleotide polymorphisms modify the transporter activity of ABCG2Kuniaki Morisaki, Robert W Robey, Csilla Ozvegy-Laczka, et al.
Pageof 2